NCT04242667

Penn Biobank Return of Research Results Program

A Randomized Protocol Evaluating Return of Actionable Genetic Research Results to Biobank Participants

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 260 (actual)
• Sponsor: Abramson Cancer Center at Penn Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The overall goal of the proposed research is to assess the feasibility of a randomized study evaluating the non-inferiority of an electronic Health (e-Health) delivery alternative (e.g. private web portal) as compared to return of actionable genetic research results with a genetic counselor.

Conditions

• Cancer
• Cardiovascular Diseases
• Hereditary Cancer
• Hereditary Cardiac Amyloidosis

Interventions

Type	Name	Description
BEHAVIORAL	e-Health (web-based) disclosure portal	Patient uses secure web-based portal to access genetic research results
BEHAVIORAL	Provider mediated disclosure	Patient has disclosure of genetic research result by a provider (genetic counselor)

Timeline

• Start date: 2020-03-01
• Primary completion: 2023-04-11
• Completion: 2023-08-01
• First posted: 2020-01-27
• Last updated: 2024-07-01

Locations

1 site across 1 country: United States